| Literature DB >> 28465627 |
Maria Falzone1, Emmanuel Crespo1, Klarissa Jones1, Gulaba Khan1, Victoria L Korn1, Amreen Patel1, Mira Patel1, Krishnaben Patel1, Carrie Perkins1, Sana Siddiqui1, Drew Stenger1, Eileen Yu1, Michael Gelber1, Robert Scheffler1, Vasyl Nayda1, Ariela Ravin1, Ronica Komal1, Jeffrey D Rudolf2, Ben Shen2, Vincent Gullo1, Arnold L Demain1.
Abstract
Streptomyces platensis MA7327 is a bacterium producing interesting antibiotics, which act by the novel mechanism of inhibiting fatty acid biosynthesis. The antibiotics produced by this actinomycete are platensimycin and platencin plus some minor related antibiotics. Platensimycin and platencin have activity against antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus; they also lack toxicity in animal models. Platensimycin also has activity against diabetes in a mouse model. We have been interested in studying the effects of primary metabolites on production of these antibiotics in our chemically defined production medium. In the present work, we tested 32 primary metabolites for their effect. They included 20 amino acids, 7 vitamins and 5 nucleic acid derivatives. Of these, only l-aspartic acid showed stimulation of antibiotic production. We conclude that the stimulatory effect of aspartic acid is due to its role as a precursor involved in the biosynthesis of aspartate-4-semialdehyde, which is the starting point for the biosynthesis of the 3-amino-2,4-dihydroxy benzoic acid portion of the platensimycin molecule.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28465627 PMCID: PMC5642980 DOI: 10.1038/ja.2017.49
Source DB: PubMed Journal: J Antibiot (Tokyo) ISSN: 0021-8820 Impact factor: 2.649